These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12665202)

  • 21. [A flow diffusion chamber for research on cells in culture].
    Akamov VS; Lavrovskaia VP; Grobova ME; Lezhnev EI
    Tsitologiia; 1990; 32(4):399-404. PubMed ID: 2238113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gauge repeatability and reproducibility for accessing variability during dissolution testing: a technical note.
    Gao Z; Moore T; Smith AP; Doub W; Westenberger B; Buhse L
    AAPS PharmSciTech; 2007 Oct; 8(4):E82. PubMed ID: 18181543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High throughput assay technologies for ion channel drug discovery.
    Zheng W; Spencer RH; Kiss L
    Assay Drug Dev Technol; 2004 Oct; 2(5):543-52. PubMed ID: 15671652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
    Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P
    J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Application of supercritical solution rapid expansion technology in preparation of fine pharmacal particles].
    Zhang ZY; Li HL; Lei ZJ
    Zhongguo Zhong Yao Za Zhi; 2006 Dec; 31(23):1933-6. PubMed ID: 17348181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of mass spectrometry for pharmaceutical profiling applications.
    Kerns EH; Di L
    Curr Drug Metab; 2006 Jun; 7(5):457-66. PubMed ID: 16787155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid-state nuclear magnetic resonance spectroscopy--pharmaceutical applications.
    Tishmack PA; Bugay DE; Byrn SR
    J Pharm Sci; 2003 Mar; 92(3):441-74. PubMed ID: 12587108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Micro and nano polycaprolactone particles preparation by pulsed back-and-forward cross-flow batch membrane emulsification for parenteral administration.
    Imbrogno A; Piacentini E; Drioli E; Giorno L
    Int J Pharm; 2014 Dec; 477(1-2):344-50. PubMed ID: 25445520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new design for the review and appraisal of semi-solid dosage forms: Semi-solid Control Diagram (SSCD).
    Nardi-Ricart A; Linares MJ; Villca-Pozo F; Pérez-Lozano P; Suñé-Negre JM; Bachs-deMiquel L; Roig-Carreras M; Suñé-Pou M; Nofrerias-Roig I; García-Montoya E
    PLoS One; 2018; 13(9):e0201643. PubMed ID: 30192759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of near-infrared spectroscopy and multipoint measurements for quality control of pharmaceutical drug products.
    Boiret M; Chauchard F
    Anal Bioanal Chem; 2017 Jan; 409(3):683-691. PubMed ID: 27422646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug targeting by retrometabolic design: soft drugs and chemical delivery systems.
    Bodor N; Buchwald P
    J Recept Signal Transduct Res; 2001; 21(2-3):287-310. PubMed ID: 11757686
    [No Abstract]   [Full Text] [Related]  

  • 32. A sensitive spectrophotometric method for the determination of sulfonamides in pharmaceutical preparations.
    Nagaraja P; Naik SD; Shrestha AK; Shivakumar A
    Acta Pharm; 2007 Sep; 57(3):333-42. PubMed ID: 17878112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the artificial membrane permeability of drugs by digital simulation.
    Nakamura M; Osakai T
    Eur J Pharm Sci; 2016 Aug; 91():154-61. PubMed ID: 27334569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated high capacity solid phase extraction-MS/MS system for pharmaceutical profiling in drug discovery.
    Kerns EH; Kleintop T; Little D; Tobien T; Mallis L; Di L; Hu M; Hong Y; McConnell OJ
    J Pharm Biomed Anal; 2004 Jan; 34(1):1-9. PubMed ID: 14738913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative structure-permeation relationships for solute transport across silicone membranes.
    Geinoz S; Rey S; Boss G; Bunge AL; Guy RH; Carrupt PA; Reist M; Testa B
    Pharm Res; 2002 Nov; 19(11):1622-9. PubMed ID: 12458667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging tools for pharmaceutical development.
    Gurny R; Mäder K
    Eur J Pharm Biopharm; 2010 Jan; 74(1):1. PubMed ID: 19919848
    [No Abstract]   [Full Text] [Related]  

  • 37. Application of the Refined Integral Method in the mathematical modeling of drug delivery from one-layer torus-shaped devices.
    Helbling IM; Ibarra JC; Luna JA
    Int J Pharm; 2012 Feb; 423(2):240-6. PubMed ID: 22178126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new combination approach of CI jet and QESD to formulate pH-susceptible amorphous solid dispersions.
    Kumar S; Linehan B; Tseng YC
    Int J Pharm; 2014 May; 466(1-2):368-74. PubMed ID: 24657557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug adsorption in human skin: a streaming potential study.
    Raiman J; Hänninen K; Kontturi K; Murtomäki L; Hirvonen J
    J Pharm Sci; 2003 Dec; 92(12):2366-72. PubMed ID: 14603482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of spray-drying parameters on phase behavior, drug distribution, and in vitro release of injectable microspheres for sustained release.
    Meeus J; Lenaerts M; Scurr DJ; Amssoms K; Davies MC; Roberts CJ; Van Den Mooter G
    J Pharm Sci; 2015 Apr; 104(4):1451-60. PubMed ID: 25648704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.